Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation

Epilepsia

Volumn 39, Issue 8, 1998, Pages 874-877

  Ettinger, Alan B ^a   Weisbrot, Deborah M ^a   Saracco, Jennifer ^a   Dhoon, Aliasgar ^a   Kanner, Andres ^b   Devinsky, Orrin ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Epilepsy; Lamotrigine; Mental retardation; Psychotropic

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; PSYCHOTROPIC AGENT; SERTRALINE; THIORIDAZINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EPILEPSY; FEMALE; HUMAN; HYPERACTIVITY; IRRITABILITY; LENNOX GASTAUT SYNDROME; MALE; MENTAL DEFICIENCY; NEGATIVE SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERKINESIS; IRRITABLE MOOD; MALE; MENTAL DISORDERS; MENTAL RETARDATION; STEREOTYPIC MOVEMENT DISORDER; TRIAZINES;

EID: 0031868679     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01183.x     Document Type: Article

References (14)

1. Brodie MJ, Richens A, Yuen A. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-8.
2. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-9
3. Walden J, Hesslinger B, van Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996;29:193-5.
4. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
5. Lund J. Epilepsy and psychiatric disorders in the mentally retarded adult. Acta Psychiatr Scand 1985;72:557-62.
6. Aman MG, Singh NN. Aberrant Behavior Checklist. East Aurora, New York: Slosson Educational Publications, 1994.
7. Small JG, Klapper MH, Milstein V, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991;48:915-21.
8. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147:431-4.
9. Smith D, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
10. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-9.
11. Burstein AH. Lamotrigine. Pharmacotherapy 1995;15:129-43.
12. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 1994;269:95-102.
13. Wolf SM, Shinnar S, Kang H, Gil KB, Moshe SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995;36:1203-5.
14. Tallian KB, Nahata MC, Lo W, Tsao C-Y. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996;37:501-2.